Delivery Order SPE2DB22D2211-SPE2DB25FSCFP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor based in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pen injectables with a ceiling value of $4,397.99. This contract, awarded on September 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. The award is not designated as a set-aside contract and was competitively awarded through open...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 12, 2025. The contract is valued at $1,201.20 under firm fixed-price terms with an ultimate completion date of September 15, 2025. This delivery order is not set-aside and represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,351.35 from the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation and is performed at the contractor's Conshohocken facility. This delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a ceiling value of $1,366.59. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 8, 2025, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) for pharmaceutical products on September 12, 2025. The award covers the supply of Trulicity 1.5 mg/0.5 mL pen injections with a ceiling value of $7,207.20 under a firm fixed-price contract type. This non-set-aside award is one of numerous delivery orders issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCFPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,006.00 by the Defense Logistics Agency on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract, designated as firm fixed price with no set-aside provisions, represents a competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. Performance will be completed by August 6, 2025, at the company's facility in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency's pharmaceutical supply chain, which provides critical medications to military healthcare systems and beneficiaries worldwide. AmerisourceBergen's comprehensive IDC vehicle enables the delivery of a broad spectrum of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The award reflects the company's continued role as a primary vendor for federal medical procurement, fulfilling the Defense Logistics Agency's operational requirements for diabetes management medications within military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/5/25 |